Evidence mapPaperPMID 40890848Full record

ReviewEuropean journal of medical research2025

Progress in brucellosis immune regulation inflammatory mechanisms and diagnostic advances.

Peipei Lu, Bin Luo, Qian Wang, Lingling Wang, Mengsi Chen, Jintong Jia, Min Yang, Junyao Pan, Jia Liu, Zhiwei Li

Abstract readReview
In one paragraph

Review in European journal of medical research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Laboratory-AcquiredPathogens (Basel, Switzerland) · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Peipei LuClinical Laboratory Center, People's Hospital of Xinjiang Uygur Autonomous Region, Urumqi, China.
Bin LuoClinical Laboratory Center, People's Hospital of Xinjiang Uygur Autonomous Region, Urumqi, China.
Qian WangClinical Laboratory Center, People's Hospital of Xinjiang Uygur Autonomous Region, Urumqi, China.
Lingling WangClinical Laboratory Center, People's Hospital of Xinjiang Uygur Autonomous Region, Urumqi, China.
Mengsi ChenClinical Laboratory Center, People's Hospital of Xinjiang Uygur Autonomous Region, Urumqi, China.
Jintong JiaClinical Laboratory Center, People's Hospital of Xinjiang Uygur Autonomous Region, Urumqi, China.
Min YangClinical Laboratory Center, People's Hospital of Xinjiang Uygur Autonomous Region, Urumqi, China.
Junyao PanClinical Laboratory Center, Karamay Central Hospital, Karamay, China.
Jia LiuClinical Laboratory Center, People's Hospital of Xinjiang Uygur Autonomous Region, Urumqi, China. 55067425@qq.com.
Zhiwei LiClinical Laboratory Center, People's Hospital of Xinjiang Uygur Autonomous Region, Urumqi, China. lizhiwei@xjrmyy.com.

Funding

In-Hospital Project of Karamay Central Hospital Grant No. 20240103Natural Science Foundation of the Xinjiang Uygur Autonomous Region Grant Nos. 2023D01C83, 2023D01C84, and 2024D01C86Outstanding Youth Science Fund of the Xinjiang Uygur Autonomous Regional Natural Science Foundation Grant No. 2022D01E30Xinjiang Uygur Autonomous Regional Science and Technology Support Program Grant No. 2022E02118Xinjiang Uygur Autonomous Regional "Tianshan" Talent Program Grant No. 2022TSYCCX0102
6 · The paper itself

Abstract

Brucellosis, a globally prevalent zoonotic disease caused by Brucella species, remains a major public health concern, especially in endemic regions. This study delves into the complex interactions between host immune responses and Brucella infection, focusing on both protective immunity and pathological inflammation. Key topics include pathogen recognition pathways, strategies employed by Brucella to evade immune defenses, and the collaborative roles of innate and adaptive immunity in driving disease progression. Emphasis is placed on how Brucella manipulates host immune regulation to establish chronic infection. From an epidemiological standpoint, this paper discusses transmission routes, risk factors, and the broader implications for global health. Additionally, this study reviews recent advancements in diagnostic techniques, particularly molecular diagnostics and novel biomarker discovery, aimed at enhancing detection accuracy and disease monitoring. Therapeutic strategies, including conventional antimicrobial treatments and emerging immune-based interventions, are also examined, with a focus on their limitations and future potential. This article further addresses challenges such as the heterogeneity of immune responses, obstacles to vaccine development, and the factors contributing to persistent infection. By clarifying the molecular and immunological mechanisms of brucellosis pathogenesis, this work underscores the importance of interdisciplinary approaches to improve understanding, diagnosis, treatment, and clinical management of this enduring infectious disease.

Indexed as

BrucellaBrucellosisInflammationAnimalsHumansImmunity, InnateBrucellosisChronic infectionDiagnosticsImmune responseImmunotherapyInflammationVaccine development

Identifiers

PMID40890848
PMCPMC12400663

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.